These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 1688311)

  • 1. The influence of agonists and antagonists of dopaminergic system on the formation of audiogenic seizures in rats during the ethanol abstinence period.
    Kaliszuk S; Borzecki Z; Swies Z
    Ann Univ Mariae Curie Sklodowska Med; 1990; 45():163-7. PubMed ID: 1688311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of dopamine neurotransmission on the development of ethanol dependence and course of abstinence syndrome].
    Samochowiec J
    Ann Acad Med Stetin; 1994; 40():195-217. PubMed ID: 7503446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 6-hydroxydopamine-induced lesions of A10 dopaminergic neurons and neuroleptic or bromocriptine treatment on ethanol withdrawal syndrome in rats.
    Trzaskowska E; Puciłowski O; Kostowski W; Bidziński A
    Pol J Pharmacol Pharm; 1983; 35(5):339-49. PubMed ID: 6141554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of bromocriptine on sexual activity in ethanol-exposed male rats.
    Kaliszuk S; Borzecki Z; Swies Z
    Ann Univ Mariae Curie Sklodowska Med; 1989; 44():109-14. PubMed ID: 2562677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of dopamine neurotransmission in ethanol dependence development and ethanol withdrawal in rats.
    Samochowiec J; Kleinrok Z; Horodnicki J
    Pharmazie; 1995 Dec; 50(12):815-8. PubMed ID: 8584559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of opioid and other systems in ethanol abstinence audiogenic seizures in the rat?
    Kotlińska J; Langwiński R
    Pol J Pharmacol Pharm; 1985; 37(2):103-11. PubMed ID: 2995952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats.
    Uzbay IT; Akarsu ES; Kayaalp SO
    Pharmacol Biochem Behav; 1994 Dec; 49(4):969-74. PubMed ID: 7886115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopaminergic agonists and antagonists on the serum prolactin levels in alcoholized rats.
    Samochowiec J; Kleinrok Z; Jagiełło-Wójtowicz E; Horodnicki J; Rommelspacher H; Schmidt LG
    Pol J Pharmacol; 1997 Aug; 49(4):221-7. PubMed ID: 9437765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological analysis of the participation of the catecholaminergic system in the development of the abstinence syndrome in rats].
    Varkov AI
    Farmakol Toksikol; 1985; 48(6):11-3. PubMed ID: 3002844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolactin in the alcohol withdrawal syndrome. Role of the dopaminergic system].
    Nardoni A; Marchetti E; Geatti O; Di Piazza V; Rossi G
    Minerva Med; 1984 Dec; 75(47-48):2833-8. PubMed ID: 6521953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acetyl-L-carnitine on ethanol consumption and alcohol abstinence syndrome in rats.
    Mangano NG; Clementi G; Costantino G; Calvani M; Matera M
    Drugs Exp Clin Res; 2000; 26(1):7-12. PubMed ID: 10761531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
    Panagis G; Hildebrand BE; Svensson TH; Nomikos GG
    Synapse; 2000 Jan; 35(1):15-25. PubMed ID: 10579804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic system does not play a major role in the precipitated cannabinoid withdrawal syndrome.
    Sañudo-Peña MC; Force M; Tsou K; McLemore G; Roberts L; Walker JM
    Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1121-4. PubMed ID: 11216447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with atypical neuroleptics sulpiride and metoclopramide increases striatal enkephalins in rat brain.
    Herman ZS; Huzarska M
    Pol J Pharmacol; 1993; 45(5-6):493-502. PubMed ID: 8012472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.
    Valdez GR; Roberts AJ; Chan K; Davis H; Brennan M; Zorrilla EP; Koob GF
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1494-501. PubMed ID: 12394282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
    Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.